| 1 | 26541774 | 18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease. | J Nucl Med | 2016 Feb |
2 |
| 2 | 26572762 | Tau imaging in neurodegenerative diseases. | Eur J Nucl Med Mol Imaging | 2016 Jun |
1 |
| 3 | 27355840 | Dynamic PET Measures of Tau Accumulation in Cognitively Normal Older Adults and Alzheimer's Disease Patients Measured Using [18F] THK-5351. | PLoS One | 2016 |
3 |
| 4 | 27794115 | In vivo visualization of tau deposits in corticobasal syndrome by 18F-THK5351 PET. | Neurology | 2016 Nov 29 |
3 |
| 5 | 28359327 | Monoamine oxidase B inhibitor, selegiline, reduces <sup>18</sup>F-THK5351 uptake in the human brain. | Alzheimers Res Ther | 2017 Mar 31 |
3 |
| 6 | 28864633 | Correlations of <sup>18</sup>F-THK5351 PET with Postmortem Burden of Tau and Astrogliosis in Alzheimer Disease. | J Nucl Med | 2018 Apr |
2 |
| 7 | 28890300 | Tau positron emission tomography using [<sup>18</sup>F]THK5351 and cerebral glucose hypometabolism in Alzheimer's disease. | Neurobiol Aging | 2017 Nov |
2 |
| 8 | 29143870 | Head to head comparison of [<sup>18</sup>F] AV-1451 and [<sup>18</sup>F] THK5351 for tau imaging in Alzheimer's disease and frontotemporal dementia. | Eur J Nucl Med Mol Imaging | 2018 Mar |
2 |
| 9 | 29542297 | Case of progressive supranuclear palsy detected by tau imaging with [<sup>18</sup> F]THK-5351 before the appearance of characteristic clinical features. | Geriatr Gerontol Int | 2018 Mar |
1 |
| 10 | 29958546 | Neuroimaging-pathological correlations of [<sup>18</sup>F]THK5351 PET in progressive supranuclear palsy. | Acta Neuropathol Commun | 2018 Jun 29 |
6 |
| 11 | 31464590 | THK5351 and flortaucipir PET with pathological correlation in a Creutzfeldt-Jakob disease patient: a case report. | BMC Neurol | 2019 Aug 29 |
4 |
| 12 | 31795034 | Rasagiline, a monoamine oxidase B inhibitor, reduces in vivo [<sup>18</sup>F]THK5351 uptake in progressive supranuclear palsy. | Neuroimage Clin | 2019 |
4 |
| 13 | 31834916 | Intra-individual correlations between quantitative THK-5351 PET and MRI-derived cortical volume in Alzheimer's disease differ according to disease severity and amyloid positivity. | PLoS One | 2019 |
1 |
| 14 | 32657863 | 18F-THK5351 PET Can Identify Lesions of Acute Traumatic Brain Injury. | Clin Nucl Med | 2020 Nov |
1 |
| 15 | 33584247 | Identification of Heterogeneous Subtypes of Mild Cognitive Impairment Using Cluster Analyses Based on PET Imaging of Tau and Astrogliosis. | Front Aging Neurosci | 2020 |
1 |
| 16 | 34028419 | Increased Uptake of 18F-THK5351 in Glioblastoma But Not in Primary Central Nervous System Lymphoma. | Clin Nucl Med | 2021 Sep 1 |
1 |
| 17 | 34305778 | Recurrent Lobar Hemorrhages and Multiple Cortical Superficial Siderosis in a Patient of Alzheimer's Disease With Homozygous APOE ε2 Allele Presenting Hypobetalipoproteinemia and Pathological Findings of <sup>18</sup>F-THK5351 Positron Emission Tomography: A Case Report. | Front Neurol | 2021 |
3 |
| 18 | 34776443 | Patterns of Distribution of 18F-THK5351 Positron Emission Tomography in Alzheimer's Disease Continuum. | J Alzheimers Dis | 2022 |
6 |
| 19 | 34912209 | <sup>18</sup>F-THK5351 Positron Emission Tomography Imaging in Neurodegenerative Tauopathies. | Front Aging Neurosci | 2021 |
4 |
| 20 | 35184428 | <sup>18</sup>F-THK5351 PET Positivity and Longitudinal Changes in Cognitive Function in β-Amyloid-Negative Amnestic Mild Cognitive Impairment. | Yonsei Med J | 2022 Mar |
1 |
| 21 | 35210989 | Imaging of Reactive Astrogliosis by Positron Emission Tomography. | Front Neurosci | 2022 |
2 |